# US 2015/0147397 A1 · Biomatrix Hydrogels and Methods of Use Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147397 A1
- Document ID: US20150147397A1
- Status: Published application
- Kind: A1
- Application number: 14/401,555
- Filed: 2013-04-29
- Published: 2015-05-28
- Earliest claimed: 2012-05-17
- Assignees: Cartiheal (2009) Ltd.
- Applicants: Cartiheal (2009) Ltd.
- Inventors: Nir Altschuler
- Web page: https://patentgrep.com/patent/US20150147397A1

## CPC

- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61F 2/28: Bones
- A61L 24/0084: {containing fillers of phosphorus-containing inorganic compounds, e.g. apatite}
- A61L 27/20: Polysaccharides
- A61L 27/24: Collagen
- A61L 27/365: {Bones}
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

This invention is directed to aragonite and calcite hydrogel biomatrices, optionally seeded with precursor cells and uses thereof in tissue engineering, regeneration and repair, including in inducing or enhancing bone formation, cartilage formation or a combination thereof in a subject, and kits related thereto.

## Claims

### Claim 1

A hydrogel biomatrix comprising a marine organism skeletal derivative biomatrix, wherein said marine organism skeletal derivative is characterized by a specific fluid uptake capacity value of at least 75%, which specific fluid uptake capacity value is determined by establishing a spontaneous fluid uptake value divided by a total fluid uptake value wherein said fluid is water, or said fluid is a protein-containing, salt-containing or carbohydrate containing solution.

### Claim 2 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said biomatrix is optionally seeded with a precursor cell, which can participate in said tissue engineering, tissue regeneration or tissue repair.

### Claim 3 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said fluid is a biologic fluid.

### Claim 4 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said biologic fluid is autologous with respect to a cell or tissue of a subject when said solid substrate is contacted with a cell or tissue of said subject.

### Claim 5 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said marine organism skeletal derivative is characterized by having a contact angle value of less than 70 degrees, when in contact with a fluid or said marine organism skeletal derivative is characterized by substantial surface roughness.

### Claim 6 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said derivative is a coral or coral derivative.

### Claim 7 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said coral or coral derivative is aragonite, calcite, hydroxyapatite, mixtures thereof, or other polymorphs of the same.

### Claim 8 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said coral or coral derivative is isolated from a Porites, Goniopora, Millepora or a Acropora species.

### Claim 9 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said biomatrix comprises aragonite or calcite particles.

### Claim 10 (depends on 9)

The hydrogel biomatrix of claim 9, wherein said aragonite or calcite particles are about 1-20 microns in diameter.

### Claim 11 (depends on 9)

The hydrogel biomatrix of claim 9, wherein said aragonite or caclite particles are about 20-400 microns in diameter.

### Claim 12 (depends on 9)

The hydrogel biomatrix of claim 9, wherein said aragonite or caclite particles are about 50-800 nanometers in diameter.

### Claim 13 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said biomatrix comprises aragonite or calcite conjugated to said hydrogel.

### Claim 14 (depends on 13)

The hydrogel biomatrix of claim 13, wherein said calcite is derived from hydro-thermically transformed aragonite.

### Claim 15 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said biomatrix is optionally seeded with cells.

### Claim 16 (depends on 15)

The hydrogel biomatrix of claim 15, wherein said cells are mesenchymal stem cells.

### Claim 17 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said hydrogel comprises chitosan fibrin, collagen, elastin, β-tricalcium phosphate, calcium phosphate, silk, aliginate, polyethylene glycol, platelet rich plasma, a glycosaminoglycan or a combination thereof.

### Claim 18 (depends on 17)

The hydrogel biomatrix of claim 17, wherein said collagen comprises cross-linked collagen.

### Claim 19 (depends on 17)

The hydrogel biomatrix of claim 17, wherein said glycosaminoglycan is hyaluronic acid, sodium hyaluronate, or a cross linked hyaluronic acid or a combination thereof.

### Claim 20 (depends on 17)

The hydrogel biomatrix of claim 17, wherein said alginate may comprise calcium alginate, cross linked calcium alginate or a combination thereof.

### Claim 21 (depends on 20)

The hydrogel biomatrix of claim 20, wherein said chitosan may comprise cross linked chitosan.

### Claim 22 (depends on 17)

The hydrogel biomatrix of claim 17, wherein said hydrogel further comprises a cytokine, a growth factor, a chelator, a cell populationa therapeutic compound, a drug, or any combination thereof.

### Claim 23 (depends on 22)

The hydrogel biomatrix of claim 22, wherein said therapeutic compound or drug comprises an anti-inflammatory compound, an anti-infective compound, a pro-angiogenic factor or a combination thereof.

### Claim 24 (depends on 1)

The hydrogel biomatrix of claim 1, wherein said hydrogel further comprises a chondrogenic support agent, an osteogenic support agent or a combination thereof.

### Claim 25 (depends on 1)

A kit for tissue engineering, tissue regeneration or tissue repair comprising the hydrogel biomatrix of claim 1.

### Claim 26

A method of tissue engineering, tissue regeneration or tissue repair in a subject comprising administering to said subject a hydrogel comprising a marine organism skeletal derivative biomatrix, wherein
said marine organism skeletal derivative is characterized by a specific fluid uptake capacity value of at least 75%, which specific fluid uptake capacity value is determined by establishing a spontaneous fluid uptake value divided by a total fluid uptake value; and
said biomatrix is optionally seeded with a precursor cell, which can participate in said tissue engineering, tissue regeneration or tissue repair.

### Claim 27 (depends on 26)

The method of claim 26, wherein said fluid is a protein-containing, salt-containing or carbohydrate containing solution.

### Claim 28 (depends on 26)

The method of claim 26, wherein said fluid is a biologic fluid.

### Claim 29 (depends on 26)

The method of claim 26, wherein said biologic fluid is autologous with respect to a cell or tissue of a subject when said solid substrate is contacted with a cell or tissue of said subject.

### Claim 30 (depends on 26)

The method of claim 26, wherein said fluid is water.

### Claim 31 (depends on 26)

The method of claim 26, wherein said marine organism skeletal derivative is characterized by having a contact angle value of less than 70 degrees, when in contact with a fluid or said marine organism skeletal derivative is characterized by substantial surface roughness.

### Claim 32 (depends on 26)

The method of claim 26, wherein said biomatrix is seeded with said precursor cell in culture in the presence of a chelator for a period of time sufficient to seed said precursor cell in said biomatrix.

### Claim 33 (depends on 26)

The method of claim 26, wherein said marine organism skeletal derivative is a coral or coral derivative.

### Claim 34 (depends on 33)

The method of claim 33, wherein said coral or coral derivative is aragonite, calcite, hydroxyapatite, mixtures thereof, or other polymorphs of the same.

### Claim 35 (depends on 33)

The method of claim 33, wherein said coral or coral derivative is isolated from a Porites, Goniopora, Millepora or a Acropora species.

### Claim 36 (depends on 35)

The method of claim 35, wherein said aragonite is from the Porites species.

### Claim 37 (depends on 36)

The method of claim 36, wherein said aragonite is Porites Lutea.

### Claim 38 (depends on 35)

The method of claim 35, wherein said aragonite is from the Millepora species

### Claim 39 (depends on 38)

The method of claim 38, wherein said aragonite is Millepora dichotoma.

### Claim 40 (depends on 35)

The method of claim 35, wherein said aragonite is from the Acropora species.

### Claim 41 (depends on 35)

The method of claim 35, wherein said aragonite is Acropora grandis.

### Claim 42 (depends on 26)

The method of claim 26, wherein said marine organism skeletal derivative is calcite.

### Claim 43 (depends on 42)

The method of claim 42, wherein said calcite is from a barnacle species

### Claim 44 (depends on 42)

The method of claim 42, wherein said calcite is from Tetraclita rufotincta.

### Claim 45 (depends on 42)

The method of claim 42, wherein said calcite is derived from hydro-thermically transformed aragonite.

### Claim 46 (depends on 26)

The method of claim 26, wherein said chelator is a calcium chelator.

### Claim 47 (depends on 46)

The method of claim 46, wherein said calcium chelator is EDTA.

### Claim 48 (depends on 46)

The method of claim 46, wherein said calcium chelator is calcein.

### Claim 49 (depends on 26)

The method of claim 26, wherein said chelator serves to eliminate diffuse calcium signaling.

### Claim 50 (depends on 26)

The method of claim 26, wherein said precursor cells are mesenchymal stem cells.

### Claim 51 (depends on 26)

The method of claim 26, wherein said coral is seeded with said precursor cell in serum-free medium.

### Claim 52 (depends on 26)

The method of claim 26, wherein said period of time sufficient to seed said precursor cells in said biomatrix is up to 72 hours.

### Claim 53 (depends on 26)

The method of claim 26, wherein said precursor cells are autologous.

### Claim 54 (depends on 26)

The method of claim 26, wherein said precursor cells are syngeneic.

### Claim 55 (depends on 26)

The method of claim 26, wherein said precursor cells are allogeneic.

### Claim 56 (depends on 26)

The method of claim 26, wherein said tissue engineering, tissue regeneration or tissue repair results in the induction or enhancement of bone formation, cartilage formation or a combination thereof.

### Claim 57 (depends on 56)

The method of claim 56, wherein said subject has osteoporosis.

### Claim 58 (depends on 56)

The method of claim 56, wherein said subject has Paget's disease, fibrous dysplasia or osteodystrophy.

### Claim 59 (depends on 56)

The method of claim 56, wherein said subject has bone infirmity.

### Claim 60 (depends on 56)

The method of claim 56, wherein said hydrogel is administered to a site of bone infirmity.

### Claim 61 (depends on 56)

The method of claim 56, wherein said enhancing bone formation comprises healing non-union fractures.

### Claim 62 (depends on 56)

The method of claim 56, wherein said method treats a cartilage defect or disorder in said subject.

### Claim 63 (depends on 62)

The method of claim 62, wherein said cartilage defect or disorder comprises a full thickness articular cartilage defect; osteoarthritis, a joint defect or a defect resulting from trauma, sports, or repetitive stress.

### Claim 64 (depends on 26)

The method of claim 26, wherein said hydrogel comprises chitosan fibrin, collagen, elastin, silk, aliginate, β-tricalcium phosphate, calcium phosphate, polyethylene glycol, platelet rich plasma, a glycosaminoglycan or a combination thereof.

### Claim 65 (depends on 64)

The method of claim 64, wherein said collagen comprises cross-linked collagen.

### Claim 66 (depends on 64)

The method of claim 64, wherein said glycosaminoglycan is hyaluronic acid, sodium hyaluronate, or a cross linked hyaluronic acid or a combination thereof.

### Claim 67 (depends on 64)

The method of claim 64, wherein said alginate may comprise calcium alginate, cross linked calcium alginate, cross linked alginate or a combination thereof.

### Claim 68 (depends on 64)

The method of claim 64, wherein said chitosan may comprise cross linked chitosan.

### Claim 69 (depends on 26)

The method of claim 26, wherein said hydrogel further comprises gelatin, glycerin, cellulose, hypromellulose, polyethylene glycol, polyethylene glycol diacrylate, poly methyl methacrylate, or combinations thereof.

### Claim 70 (depends on 26)

The method of claim 26, wherein said hydrogel further comprises calcium phosphate, calcium sulfate,

### Claim 71 (depends on 26)

The method of claim 26, wherein said hydrogel further comprises a cytokine, a growth factor, a chelator, a cell populationa therapeutic compound, a drug, or any combination thereof.

### Claim 72 (depends on 71)

The method of claim 71, wherein said therapeutic compound or drug comprises an anti-inflammatory compound, an anti-infective compound, a pro-angiogenic factor or a combination thereof.

### Claim 73 (depends on 26)

The method of claim 26, wherein said hydrogel further comprises a chondrogenic support agent, an osteogenic support agent or a combination thereof.

### Claim 74 (depends on 26)

The method of claim 26, wherein said hydrogel biomatrix can be used as a bone filler or bone substitute material.

### Claim 75 (depends on 26)

The method of claim 26, wherein said hydrogel biomatrix further comprises a bone filler or bone substitute material

### Claim 76 (depends on 26)

The method of claim 26, wherein said marine organism skeletal derivative is aragonite and said method further comprises converting said marine organism skeletal derivative to hydroxyapatite.

### Claim 77 (depends on 26)

The method of claim 26, wherein said method further comprises inducing or enhancing repair, regeneration or enhancement of formation of cartilage, bone or a combination thereof.

### Claim 78 (depends on 77)

The method of claim 77, wherein said method further comprises exposing said site of cartilage repair, and optionally exposing bone tissue located proximally to the site of cartilage repair in said subject and implanting said hydrogel comprising a marine organism skeletal derivative biomatrix therein.

### Claim 79 (depends on 78)

The method of claim 78, further comprising the step of affixing at least a portion of said solid substrate within bone located proximally to said site of cartilage repair.

### Claim 80 (depends on 78)

The method of claim 78, wherein said method promotes adhesion, proliferation or differentiation, or a combination thereof, of a cell population to said solid substrate.

### Claim 81 (depends on 78)

The method of claim 78, further comprising seeding said solid substrate with mesenchymal stem cells prior to said implanting.

### Claim 82 (depends on 78)

The method of claim 78, wherein said method comprises positioning said solid substrate below the upper limit of said site such that said solid substrate does not protrude above an upper limit of said site.

### Claim 83 (depends on 56)

The method of claim 56, wherein said subject is afflicted with a cartilage and/or bone defect or disorder or disease.

### Claim 84 (depends on 56)

The method of claim 56, wherein said subject is a human subject.

### Claim 85 (depends on 56)

The method of claim 56, wherein said subject is an animal subject.

### Claim 86 (depends on 56)

The method of claim 56, wherein said cartilage defect or disorder comprises a full or partial thickness articular cartilage defect; osteochondral defect; osteoarthritis, bone marrow edema a joint defect or a defect resulting from trauma, sports, repetitive stress or osteoarthritis.

### Claim 87 (depends on 26)

The method of claim 26, wherein said method further comprises forming a three-dimensional bone filler in sequential cross-sectional layers in accordance with a model of the bone filler, comprising said hydrogel biomatrix.
